MONTE ROSA THERAPEUTIC
5.0000
08-October-24 15:59:57
15 minutes delayed
Stocks
-0.0700
-1.38%
Today's range
4.9500 - 5.1900
ISIN
N/A
Source
NASDAQ
-
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
27 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
26 Oct 2023 16:30:50 By Nasdaq GlobeNewswire
-
17 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
17 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
10 Aug 2023 07:15:00 By Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics Appoints Dr. Anthony M. Manning to Board of Directors
26 Jul 2023 07:30:00 By Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics to Present at Upcoming Investor and Industry Conferences
30 May 2023 16:30:00 By Nasdaq GlobeNewswire
-
23 May 2023 07:30:00 By Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update
11 May 2023 07:30:00 By Nasdaq GlobeNewswire
-
17 Apr 2023 16:30:00 By Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics Appoints Dr. Jan Skvarka to Board of Directors
23 Mar 2023 07:30:00 By Nasdaq GlobeNewswire
-
16 Mar 2023 07:30:00 By Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics to Present at Upcoming Investor Conferences
03 Feb 2023 07:30:00 By Nasdaq GlobeNewswire
-
09 Jan 2023 07:30:00 By Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
04 Jan 2023 07:30:01 By Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics Reports Third Quarter 2022 Financial Results and Business Updates
10 Nov 2022 07:30:00 By Nasdaq GlobeNewswire
-
01 Nov 2022 07:30:00 By Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics Announces Participation in Upcoming Investor Conferences
31 Oct 2022 16:30:00 By Nasdaq GlobeNewswire
-
20 Oct 2022 16:30:00 By Nasdaq GlobeNewswire